Rhythm Pharmaceuticals
1D
1W
1M
3M
1Y
5Y
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell RYTM and other ETFs, options, and stocks.About RYTM
Rhythm Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in developing and commercializing peptide therapeutics for the treatment of gastrointestinal diseases and genetic deficiencies. The firm focuses on the treatment for Prader-Willi Syndrome and Pro-Opiomelanocortin deficiency obesity.
CEODavid P. Meeker
CEODavid P. Meeker
Employees140
Employees140
HeadquartersBoston, Massachusetts
HeadquartersBoston, Massachusetts
Founded2008
Founded2008
Employees140
Employees140
RYTM Key Statistics
Market cap1.54B
Market cap1.54B
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume601.32K
Average volume601.32K
High today$27.93
High today$27.93
Low today$26.61
Low today$26.61
Open price$26.68
Open price$26.68
Volume681.48K
Volume681.48K
52 Week high$34.99
52 Week high$34.99
52 Week low$3.04
52 Week low$3.04
Analyst ratings
78%
of 9 ratingsBuy
77.8%
Hold
22.2%
Sell
0%
RYTM Earnings
-$1.05
-$0.70
-$0.35
$0.00
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated— per share
Estimated— per share
ActualExpected Mar 1, Pre-Market
ActualExpected Mar 1, Pre-Market